Literature DB >> 3653508

Proteoglycan metabolism associated with mouse metanephric development: morphologic and biochemical effects of beta-D-xyloside.

J L Platt1, D M Brown, K Granlund, T R Oegema, D J Klein.   

Abstract

Morphology and de novo incorporation of [35S]sulfate into proteoglycans were studied in fetal mouse kidneys at the onset of organogenesis. Branching morphogenesis and nephron development in organ culture and in vivo were associated with de novo synthesis of chondroitin-SO4 and heparan-SO4 proteoglycans. The role of proteoglycan metabolism in metanephrogenesis was then studied by analysis of the effects of p-nitrophenyl-beta-D-xylopyranoside (beta-D-xyloside) on renal development and proteoglycan metabolism. Incubation of fetal kidneys in beta-D-xyloside at concentrations of 1.0 and 0.5 mM, but not at 0.1 mM, caused inhibition of ureteric branching and markedly diminished synthesis of a large Mr 2.0 X 10(6) Da chondroitin-SO4 proteoglycan. Incorporation of [35S]sulfate was stimulated at all beta-D-xyloside concentrations, reflecting synthesis of xyloside initiated dermatan-35SO4 chains. In contrast to dramatic effects on chondroitin-SO4 synthesis and ureteric branching, beta-D-xyloside had no effect on heparan-SO4 synthesis or on development of the glomerulus and glomerular basement membrane. We thus characterize the proteoglycans synthesized early in the course of renal organogenesis and describe observations which suggest an association between metabolism of chondroitin-SO4 proteoglycan and development of the ureter.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3653508     DOI: 10.1016/0012-1606(87)90388-5

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  16 in total

1.  Glycoconjugate histochemistry in the duodenum of fetal and adult fallow deer.

Authors:  P Scocco; V Pedini; O Fagioli; P Ceccarelli
Journal:  Vet Res Commun       Date:  2001-01       Impact factor: 2.459

2.  Growth and morphogenesis of embryonic mouse organs on biopore membrane.

Authors:  P Hardman; B J Klement; B S Spooner
Journal:  In Vitro Cell Dev Biol       Date:  1990-12

3.  The future of organ replacement: needs, potential applications, and obstacles to application.

Authors:  M Cascalho; J L Platt
Journal:  Transplant Proc       Date:  2006-03       Impact factor: 1.066

4.  Identity of the core proteins of the large chondroitin sulphate proteoglycans synthesized by skeletal muscle and prechondrogenic mesenchyme.

Authors:  D A Carrino; J E Dennis; R F Drushel; S E Haynesworth; A I Caplan
Journal:  Biochem J       Date:  1994-02-15       Impact factor: 3.857

Review 5.  Growth factor-heparan sulfate "switches" regulating stages of branching morphogenesis.

Authors:  Sanjay K Nigam; Kevin T Bush
Journal:  Pediatr Nephrol       Date:  2014-02-02       Impact factor: 3.714

Review 6.  New and old technologies for organ replacement.

Authors:  Jeffrey L Platt; Marilia Cascalho
Journal:  Curr Opin Organ Transplant       Date:  2013-04       Impact factor: 2.640

7.  Investigating the elusive mechanism of glycosaminoglycan biosynthesis.

Authors:  Xylophone V Victor; Thao K N Nguyen; Manivannan Ethirajan; Vy M Tran; Khiem V Nguyen; Balagurunathan Kuberan
Journal:  J Biol Chem       Date:  2009-07-23       Impact factor: 5.157

8.  Mannose-induced dysmorphogenesis of metanephric kidney. Role of proteoglycans and adenosine triphosphate.

Authors:  Z Z Liu; F A Carone; T M Dalecki; B Lelongt; E I Wallner; Y S Kanwar
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

9.  BODIPY-Conjugated Xyloside Primes Fluorescent Glycosaminoglycans in the Inner Ear of Opsanus tau.

Authors:  Holly A Holman; Vy M Tran; Mausam Kalita; Lynn N Nguyen; Sailaja Arungundram; Balagurunathan Kuberan; Richard D Rabbitt
Journal:  J Assoc Res Otolaryngol       Date:  2016-09-12

Review 10.  Heparan Sulfate Proteoglycan Metabolism and the Fate of Grafted Tissues.

Authors:  Jeffrey L Platt; Lucile E Wrenshall; Geoffrey B Johnson; Marilia Cascalho
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.